Hormone replacement therapy and the cardiovascular system: lessons learned and unanswered questions
Cardiovascular disease is the leading cause of death among women in the US, exceeding
breast cancer mortality in women of all ages. Women present with cardiovascular disease a …
breast cancer mortality in women of all ages. Women present with cardiovascular disease a …
Isoflavonoid Compounds from Red Clover (Trifolium pratense) Protect from Inflammation and Immune Suppression Induced by UV Radiation¶
S Widyarini, N Spinks, AJ Husband… - Photochemistry and …, 2001 - Wiley Online Library
Isoflavones derived from many edible plants have been reported to possess significant
antioxidant, estrogenic and tyrosine kinase inhibitory activity. Genistein has been found …
antioxidant, estrogenic and tyrosine kinase inhibitory activity. Genistein has been found …
Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-κB suppression in …
L Wang, XM Qiu, Q Hao, DJ Li - Cell Death & Disease, 2013 - nature.com
Abstract Bu-Shen-Ning-Xin Decoction (BSNXD) administration has alleviated the early
pathologic damage of atherosclerosis by inhibiting the adhesion molecule expression and …
pathologic damage of atherosclerosis by inhibiting the adhesion molecule expression and …
Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells
L Wang, Q Hao, YD Wang, WJ Wang, DJ Li - Atherosclerosis, 2011 - Elsevier
OBJECTIVE: The risk for atherosclerosis is increased in postmenopausal women.
Dehydroepiandrosterone (DHEA) is postulated to have anti-atherogenic properties, but the …
Dehydroepiandrosterone (DHEA) is postulated to have anti-atherogenic properties, but the …
[HTML][HTML] Terapia hormonal de la menopausia,¿ por qué prescribirla?
S Vallejo Maldonado - Revista Peruana de Ginecología y Obstetricia, 2018 - scielo.org.pe
Durante el climaterio, la mayoría de las mujeres presenta muchos síntomas que afectan su
calidad de vida. Estos síntomas han sido vinculados con trastornos de la neuroquímica …
calidad de vida. Estos síntomas han sido vinculados con trastornos de la neuroquímica …
Современные подходы к профилактике и лечению сердечно-сосудистых заболеваний у женщин в постменопаузе: роль заместительной гормональной …
СР Гиляревский - Сердце: журнал для практикующих врачей, 2006 - elibrary.ru
В настоящее время данные об эффективности и безопасности применения
заместительной гормональной терапии (ЗГТ) остаютсядостаточно противоречивыми …
заместительной гормональной терапии (ЗГТ) остаютсядостаточно противоречивыми …
Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment: open prospective study with Doppler ultrasonography in internal …
C Castelo-Branco, M Garcı́a-Fantini, J Haya - Maturitas, 2005 - Elsevier
Background: Arteriosclerosis is the main cause of ischaemic ictus. The middle cerebral and
anterior cerebral arteries, which irrigate over 70% of the entire cerebral tissue, spring from …
anterior cerebral arteries, which irrigate over 70% of the entire cerebral tissue, spring from …
[HTML][HTML] La terapia hormonal de la menopausia¿ disminuye el riesgo de enfermedades crónicas?
JE Blümel, E Arteaga - Revista médica de Chile, 2018 - SciELO Chile
Resumen BLUMEL, JUAN ENRIQUE y ARTEAGA, EUGENIO. La terapia hormonal de la
menopausia¿ disminuye el riesgo de enfermedades crónicas?. Rev. méd. Chile [online] …
menopausia¿ disminuye el riesgo de enfermedades crónicas?. Rev. méd. Chile [online] …
Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease
Objective: Oral estrogens improve endothelial function, and for this reason may be
considered cardioprotective; however, in women with coronary heart disease there may also …
considered cardioprotective; however, in women with coronary heart disease there may also …
Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?
D Crook - Trials, 2001 - Springer
Postmenopausal hormone replacement therapy (HRT) with oral oestrogen was predicted to
reduce coronary heart disease (CHD) risk by 50%. Randomized controlled trials show no …
reduce coronary heart disease (CHD) risk by 50%. Randomized controlled trials show no …